Clinical significance of metastatic-tumor HER2 status in patients with HER2-positive primary breast cancer

被引：0
|
作者：
Niikura, N.
Liu, J.
Hayashi, N.
Mittendorf, E. A.
Gong, Y.
Palla, S. L.
Tokuda, Y.
Gonzalez-Angulo, A. M.
Hortobagyi, G. N.
Ueno, N. T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Tokai Univ, Sch Med, Kanagawa 2591100, Japan
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
545
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
    Hosonaga, Mari
    Arima, Yoshimi
    Sampetrean, Oltea
    Komura, Daisuke
    Koya, Ikuko
    Sasaki, Takashi
    Sato, Eiichi
    Okano, Hideyuki
    Kudoh, Jun
    Ishikawa, Shumpei
    Saya, Hideyuki
    Ishikawa, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [42] Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
    F Carabantes-Ocón
    E Saez-Lara
    L Burgos-Garcia
    E Villar-Chamorro
    A Casaus-Hazañas
    S Luna
    C Martínez
    Breast Cancer Research, 9
  • [43] Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls
    Leyland-Jones, Brian
    Smith, Brian R.
    LANCET ONCOLOGY, 2011, 12 (03): : 286 - 295
  • [44] Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients
    Ha, June-Hyung
    Seong, Min-Ki
    Kim, Eun-Kyu
    Lee, Jin Kyung
    Seol, Hyesil
    Lee, Ju Young
    Byeon, Jangmoo
    Sohn, Yeun-Ju
    Koh, Jae Soo
    Park, In-Chul
    Noh, Woo Chul
    Kim, Hyun-Ah
    JOURNAL OF BREAST CANCER, 2014, 17 (01) : 33 - 39
  • [45] Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
    Zhang, Shaohua
    Li, Lei
    Wang, Tao
    Bian, Li
    Hu, Haixu
    Xu, Chunhong
    Liu, Bing
    Liu, Yi
    Cristofanilli, Massimo
    Jiang, Zefei
    BMC CANCER, 2016, 16
  • [46] Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
    Shaohua Zhang
    Lei Li
    Tao Wang
    Li Bian
    Haixu Hu
    Chunhong Xu
    Bing Liu
    Yi Liu
    Massimo Cristofanilli
    Zefei Jiang
    BMC Cancer, 16
  • [47] Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer
    Wang, Yihong
    Singh, Kamaljeet
    Dizon, Don
    Graves, Teresa
    Amin, Ali
    Yakirevich, Evgeny
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 667 - 676
  • [48] Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer
    Yihong Wang
    Kamaljeet Singh
    Don Dizon
    Teresa Graves
    Ali Amin
    Evgeny Yakirevich
    Breast Cancer Research and Treatment, 2021, 186 : 667 - 676
  • [49] Prospective characterization of HER2-positive circulating tumor cells in patients with HER2-negative metastatic breast cancer
    Krop, Ian E.
    Macrae, Erin
    Galler, Sarah R.
    Bischoff, Farideh
    Fauni, Romeo
    Sales, Edgar
    Huynh, Lan
    Mitchell, Christine
    Clarin-Tamayo, Trisky
    Anderson, Mark
    Abad, Leslie
    Winer, Eric
    CANCER RESEARCH, 2015, 75
  • [50] Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer
    Kutlu, Yasin
    Cekin, Ruhper
    Aydin, Sabin Goktas
    Shbair, Abdallah T. M.
    Bilici, Ahmet
    Arici, Serdar
    Oven, Bala Basak
    Acikgoz, Ozgur
    Ozcan, Erkan
    Olmez, Omer Fatih
    Cakir, Asli
    Seker, Mesut
    CURRENT PROBLEMS IN CANCER, 2024, 50
12345